Diluted EPS

 
News Articles for Diluted EPS top ^
2014 Adjusted Diluted EPS Guidance Range Increases to $3.54 to $3.60 PITTSBURGH , Oct.
Sign-up for Mylan Third Quarter 2014 Adjusted Diluted EPS Increases 41% to $1.16 investment picks
2014/10/16
Regulatory News: Third-Quarter 2014 Reported diluted earnings per share of $1.38, down by $0.06 or 4.2% versus $1.44 in 2013 Excluding unfavorable currency of $0.20, reported diluted earnings per share up by $0.14 or 9.7% versus $1.44 in 2013 as detailed in the attached Schedule 13 Adjusted diluted earnings per share of $1.39, down by $0.05 or 3.5% versus $1.44 in 2013 Excluding unfavorable currency of $0.20, adjusted diluted earnings per share up by $0.15 or 10.4% versus $1.44 in 2013 as detailed in the attached Schedule 12 Cigarette shipment volume of 222.3 billion units, down by 0.4% excluding acquisitions Reported
Sign-up for Philip Morris International Inc. (PMI) Reports 2014 Third-Quarter Results; Revises 2014 Full-Year Reported Diluted EPS Forecast to a Range of $4.76 to $4.81 Reflecting Currency investment picks
Bally Technologies, Inc. (NYSE: BYI) Bally Technologies' Chief Executive Officer Richard Haddrill (Photo: Business Wire) Bally Technologies, Inc. (NYSE: BYI) (“Bally” or the “Company”), a leader in gaming machines, table game products, casino-management systems, interactive applications, and networked and server-based systems for the global gaming industry, today announced record first quarter revenue of $321 million and Adjusted EPS of $1.17 for the three months ended September 30, 2014.
Sign-up for Bally Technologies, Inc. Reports Adjusted EPS of $1.17 and GAAP Diluted EPS of $0.75 for the First Quarter of Fiscal 2015 investment picks
- Market growth continued in Hawaii, container volume up 3.8 percent YOY - Freight yields increased across major trade lanes - 3Q14 Revenue of $441.8 million, up 6.5 percent YOY - Ocean transportation operating income of $42.6 million, up 67.1 percent YOY - 3Q14 Net Income of $21.5 million, EBITDA of $62.2 million - Diluted EPS of $0.50, up 25.0 percent YOY HONOLULU , Nov.
Sign-up for Matson, Inc. Announces Third Quarter 2014 Diluted EPS Of $0.50 investment picks
REX American Resources Corporation (NYSE: REX) today reported record financial results for its fiscal 2014 third quarter (“Q3 ‘14”) ended October 31, 2014.
Sign-up for REX American Resources’ Third Quarter Diluted EPS Rise 136% to a Record $2.86 investment picks
Cabot Corporation (NYSE: CBT) today announced results for its fourth quarter and full fiscal year 2014.
Sign-up for Cabot Corp Reports Fourth Quarter Adjusted EPS of $0.85 and Diluted EPS of $0.51 investment picks
http://media.marketwire.com/attachments/201405/249030_panera-logo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1154579&ProfileId=051205&sourceType=1 ST.
Sign-up for Panera Bread Company Reports Q3 2014 Diluted EPS of $1.46 investment picks
-Third Quarter 2014 Financial Results Conference Call to be Held on Oct.
Sign-up for Mylan Increases Third Quarter and Full Year 2014 Adjusted Diluted EPS Guidance Range investment picks
Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) today reported that total revenues for the third quarter of 2014 are expected to be approximately $15 million and that non-GAAP earnings per diluted share are expected to be between $0.33 and $0.37. This compares with prior guidance issued on August 4, 2014 for total revenues to be between $13 million and $14 million and for non-GAAP earnings per diluted share to be between $0.26 and $0.29. Ligand also expects total revenues for the fourth quarter to be between $22.5 million and $24.5 million.
Sign-up for Ligand Reports Third Quarter Revenues and Expected Diluted EPS investment picks
Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder and spine, announced today revenue of $57.9 million for the third quarter of 2014, a 4% increase over $55.7 million in the third quarter of 2013.
Sign-up for Exactech Q3 Revenue Up 4% to $57.9 Million; Net Income Down 6% to $3.0 Million Due to Currency Losses; Q3 Diluted EPS $0.21 vs. $0.23 investment picks
United Natural Foods, Inc. (Nasdaq: UNFI) (the "Company" or "UNFI") today reported financial results for the first quarter of fiscal 2015 ended November 1, 2014.
Sign-up for United Natural Foods, Inc. Announces First Quarter Fiscal 2015 Diluted EPS of $0.66, a 17.9% Increase Over the Prior Year Period investment picks
Revenue and Capital Grow, Expenses Controlled PITTSBURGH , Oct.
Sign-up for PNC Reports Third Quarter Net Income of $1.0 Billion and $1.79 Diluted EPS investment picks
BlackRock, Inc. (NYSE:BLK): FINANCIAL RESULTS (in millions, except per share data) Q3 2014
Sign-up for BlackRock Reports Third Quarter 2014 Diluted EPS of $5.37, or $5.21 as adjusted investment picks
2014/10/22
Third Quarter Financial Highlights * *All comparisons versus third quarter 2013.
Sign-up for MarketAxess Reports Third Quarter 2014 Revenues of $64.2 Million, Pre-Tax Income of $28.3 Million and Diluted EPS of $0.46 investment picks
Webcast: Today, October 24, 2014 at 10:00 a.m. ET www.bbgi.com Replay information provided below  NAPLES, Fla., Oct.
Sign-up for Beasley Broadcast Group Reports Third Quarter Net Revenue From Continuing Operations of $13.0 Million, Net Revenue From Discontinued Operations of $11.5 Million and Diluted EPS From Continuing and Discontinued Operations of $0.11 investment picks
TransAct Technologies Incorporated (Nasdaq:TACT) (“TransAct” or the “Company”) today reported operating results for the third quarter ended September 30, 2014, as summarized below: Bart Shuldman, Chairman and Chief Executive Officer of TransAct, commented, “As anticipated, the third quarter results reflect lower overall contributions from casino and gaming operations as a result of ongoing challenges in the gaming industry.
Sign-up for TransAct Technologies Reports 2014 Third Quarter Revenue of $13.4 Million and Diluted EPS of $0.01 investment picks

Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Diluted EPS
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry |  Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry

Previous: Diluted Earnings Per  |  Next: Diluted EPS Guidance